U.S. Trade Policies Threaten To Undermine Successful Global Health Programs
The Hill: U.S. trade policy could raise drug prices, at home and abroad
Rep. Jan Schakowsky (D-Ill.) and Peter Maybarduk, director of Public Citizen’s Global Access to Medicines program
“…[With the creation of PEPFAR, t]he United States put public health needs ahead of pharmaceutical industry profits and made a transformative contribution to global health. Now we are backtracking. Even as we reduce budgets for U.S.-led global health programs, our trade policy would raise future health care costs at the expense of people’s access to needed medicines, not only for HIV, but for cancer, heart disease, and many other deadly conditions. … Trade policies negotiated in secret should not be allowed to undermine our global health work or the opportunity to reduce costs at home…” (3/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.